Our recent work has shown that smooth muscle alpha actin (?SMA) is a marker of mesenchymal progenitor cells that expand rapidly following fracture, and show significant contribution to fibrous tissue, osteoblast, and chondrocyte lineages within a fracture callus. Gene expression analysis of isolated ?SMA- labeled progenitor cells revealed that the Notch signaling pathway is significantly decreased during the early stages of fracture healing. Previous studies have shown that Notch signaling exhibits different effects dependent on the stage of osteoprogenitor maturation. We hypothesize that decreases in Notch signaling regulate periosteal progenitor cells expansion, migration and differentiation into mature mesenchymal lineages in the fracture callus. We propose to evaluate the effects of Notch using stage specific genetic Notch gain- and loss-of-function models during fracture healing. We will also evaluate the inhibition of Notch using small peptide SAHM1 that directly interferes with the Notch transcriptional complex. This approach will provide evidence for potential future application to accelerate or improve fracture healing.
In Aim 1 we will evaluate the effects of Notch overexpression. Overexpression will be achieved by directing forced Notch 1 intracellular domain (NICD1) expression to different stages of the osteogenic lineage. For timed activation of the NICD1 following generation of fractures, we propose to use stage- specific inducible-Cre transgenes. ?SMACreERT2 mice will be used to target Notch overexpression to progenitor stage while overexpression in osteoblasts/osteocytes will be achieved by using DMP1-CreERT2 mice. Effects of Notch modulation will be assessed by evaluating progress of callus formation, and changes in bone strength and stiffness during fracture healing. We will also examine the mechanisms of effects of Notch overexpression on PPCs using in vitro and in vivo approaches to study effects on proliferation, migration and differentiation.
In Aim 2 we will determine the effects of stage-specific Notch inhibition on fracture healing. To disrupt Notch signaling, we will use a transgenic model in which a direct transcriptional effector of Notch signaling, Rbpj?, is deleted (Rbpj?flox) following generation of fracture. In vitro and in vivo evaluation of Notch inhibition using PPCs will be evaluated. We will extend the inhibition studies to evaluate the treatment with Notch transcription factor complex inhibitor SAHM1 (stapled a-helical peptides derived from MAML1) on fracture healing. Our results will provide a better understanding of the role of Notch signaling during fracture healing and will evaluate the future therapeutic modulation of the healing process.

Public Health Relevance

The effects of Notch signaling modulation will be evaluated In vivo using stage specific Notch gain- and loss-of- function models during fracture healing. We postulate that inhibition of Notch using small peptide SAHM1 that directly inhibits Notch transcriptional complex will provide evidence for potential future application to accelerate or improve fracture healing. Our results will provide a better understanding of the role of Notch signaling during fracture healing and will evaluate the potential for therapeutic modulation of the healing process.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR055607-09
Application #
9727776
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Chen, Faye H
Project Start
2011-02-01
Project End
2021-05-31
Budget Start
2019-06-01
Budget End
2021-05-31
Support Year
9
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Dentistry
Type
Schools of Dentistry/Oral Hygn
DUNS #
022254226
City
Farmington
State
CT
Country
United States
Zip Code
06030
Wee, Natalie K Y; Sinder, Benjamin P; Novak, Sanja et al. (2018) Skeletal phenotype of the neuropeptide Y knockout mouse. Neuropeptides :
Gr?evi?, Danka; Sironi, Marina; Valentino, Sonia et al. (2018) The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair. Front Immunol 9:417
Aravamudhan, Aja; Ramos, Daisy M; Nip, Jonathan et al. (2018) Micro-Nanostructures of Cellulose-Collagen for Critical Sized Bone Defect Healing. Macromol Biosci 18:
Matsumoto, Kei; Xavier, Sandhya; Chen, Jun et al. (2017) Instructive Role of the Microenvironment in Preventing Renal Fibrosis. Stem Cells Transl Med 6:992-1005
Matthews, Brya G; Roeder, Emilie; Wang, Xi et al. (2017) Splenomegaly, myeloid lineage expansion and increased osteoclastogenesis in osteogenesis imperfecta murine. Bone 103:1-11
Vidovic, I; Banerjee, A; Fatahi, R et al. (2017) ?SMA-Expressing Perivascular Cells Represent Dental Pulp Progenitors In Vivo. J Dent Res 96:323-330
Vidovic Zdrilic, I; de Azevedo Queiroz, I O; Matthews, B G et al. (2017) Mineral trioxide aggregate improves healing response of periodontal tissue to injury in mice. J Periodontal Res 52:1058-1067
Sagomonyants, K; Kalajzic, I; Maye, P et al. (2017) FGF Signaling Prevents the Terminal Differentiation of Odontoblasts. J Dent Res 96:663-670
Matthews, Brya G; Torreggiani, Elena; Roeder, Emilie et al. (2016) Osteogenic potential of alpha smooth muscle actin expressing muscle resident progenitor cells. Bone 84:69-77
Matic, Igor; Matthews, Brya G; Wang, Xi et al. (2016) Quiescent Bone Lining Cells Are a Major Source of Osteoblasts During Adulthood. Stem Cells 34:2930-2942

Showing the most recent 10 out of 25 publications